Ali Faraz Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
4
Insider Sells Sum
$91,913.05

Insider Activity of Ali Faraz

According to the SEC Form 4 filings, Ali Faraz, being in a position of

  1. Chief Executive Officer at Tenaya Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 43610 shares for $32,182,
    over all time since 2023-08-16, has bought 0 shares, and sold 92742 shares for $143,717.

Biography of Ali Faraz

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $32,1824100

Comparison of Insiders on Amount of Buys and Sells

2026-08-17SaleTenaya Therapeutics, Inc.
TNYA
Chief Executive Officer
22,232
0.0104%
$0.71$15,778-12.93%
2026-05-18SaleTenaya Therapeutics, Inc.
TNYA
Chief Executive Officer
3,390
0.0021%
$0.79$2,690-10.42%
2026-02-17SaleTenaya Therapeutics, Inc.
TNYA
Chief Executive Officer
14,862
0.0091%
$0.64$9,557+12.75%
2025-11-17SaleTenaya Therapeutics, Inc.
TNYA
Chief Executive Officer
3,126
0.002%
$1.33$4,158-42.14%
2025-08-18SaleTenaya Therapeutics, Inc.
TNYA
Chief Executive Officer
14,533
0.0089%
$1.25$18,210-37.3%
2025-05-16SaleTenaya Therapeutics, Inc.
TNYA
Chief Executive Officer
3,189
0.0019%
$0.44$1,412+72.01%
2025-03-10SaleTenaya Therapeutics, Inc.
TNYA
Chief Executive Officer
9,741
0.0067%
$0.54$5,245+44.35%
2024-08-16SaleTenaya Therapeutics, Inc.
TNYA
Chief Executive Officer
9,748
0.0131%
$2.89$28,216-64.36%
2024-02-16SaleTenaya Therapeutics, Inc.
TNYA
Chief Executive Officer
6,358
0.0087%
$5.86$37,258-53.48%
2023-08-16SaleTenaya Therapeutics, Inc.
TNYA
Chief Executive Officer
5,563
0.0083%
$3.81$21,195-8.72%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.